Lv4
450 积分 2026-05-20 加入
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma
18小时前
待确认
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
22小时前
已完结
European Association for the Study of the Liver (EASL) Liver Cancer Summit 2025
2天前
已完结
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
3天前
已完结
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation
17天前
已关闭
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
18天前
已完结
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
18天前
已完结
Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma
18天前
已完结
Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment
18天前
已完结
Up‐to‐seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child–Pugh grade deterioration after initial conventional transarterial chemoembolization
19天前
已完结
皖公网安备34019202002308
